These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 24514864)

  • 1. P7C3 and an unbiased approach to drug discovery for neurodegenerative diseases.
    Pieper AA; McKnight SL; Ready JM
    Chem Soc Rev; 2014 Oct; 43(19):6716-26. PubMed ID: 24514864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P7C3-A20 treatment one year after TBI in mice repairs the blood-brain barrier, arrests chronic neurodegeneration, and restores cognition.
    Vázquez-Rosa E; Shin MK; Dhar M; Chaubey K; Cintrón-Pérez CJ; Tang X; Liao X; Miller E; Koh Y; Barker S; Franke K; Crosby DR; Schroeder R; Emery J; Yin TC; Fujioka H; Reynolds JD; Harper MM; Jain MK; Pieper AA
    Proc Natl Acad Sci U S A; 2020 Nov; 117(44):27667-27675. PubMed ID: 33087571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotective efficacy of a proneurogenic compound after traumatic brain injury.
    Blaya MO; Bramlett HM; Naidoo J; Pieper AA; Dietrich WD
    J Neurotrauma; 2014 Mar; 31(5):476-86. PubMed ID: 24070637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotective Efficacy of an Aminopropyl Carbazole Derivative P7C3-A20 in Ischemic Stroke.
    Wang SN; Xu TY; Wang X; Guan YF; Zhang SL; Wang P; Miao CY
    CNS Neurosci Ther; 2016 Sep; 22(9):782-8. PubMed ID: 27333812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P7C3 neuroprotective chemicals block axonal degeneration and preserve function after traumatic brain injury.
    Yin TC; Britt JK; De Jesús-Cortés H; Lu Y; Genova RM; Khan MZ; Voorhees JR; Shao J; Katzman AC; Huntington PJ; Wassink C; McDaniel L; Newell EA; Dutca LM; Naidoo J; Cui H; Bassuk AG; Harper MM; McKnight SL; Ready JM; Pieper AA
    Cell Rep; 2014 Sep; 8(6):1731-1740. PubMed ID: 25220467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of a neuroprotective chemical, (S)-N-(3-(3,6-dibromo-9H-carbazol-9-yl)-2-fluoropropyl)-6-methoxypyridin-2-amine [(-)-P7C3-S243], with improved druglike properties.
    Naidoo J; De Jesus-Cortes H; Huntington P; Estill S; Morlock LK; Starwalt R; Mangano TJ; Williams NS; Pieper AA; Ready JM
    J Med Chem; 2014 May; 57(9):3746-54. PubMed ID: 24697290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of proneurogenic, neuroprotective small molecules.
    MacMillan KS; Naidoo J; Liang J; Melito L; Williams NS; Morlock L; Huntington PJ; Estill SJ; Longgood J; Becker GL; McKnight SL; Pieper AA; De Brabander JK; Ready JM
    J Am Chem Soc; 2011 Feb; 133(5):1428-37. PubMed ID: 21210688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurotherapeutic capacity of P7C3 agents for the treatment of Traumatic Brain Injury.
    Blaya MO; Wasserman JM; Pieper AA; Sick TJ; Bramlett HM; Dietrich WD
    Neuropharmacology; 2019 Feb; 145(Pt B):268-282. PubMed ID: 30236963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotective efficacy of P7C3 compounds in primate hippocampus.
    Bauman MD; Schumann CM; Carlson EL; Taylor SL; Vázquez-Rosa E; Cintrón-Pérez CJ; Shin MK; Williams NS; Pieper AA
    Transl Psychiatry; 2018 Sep; 8(1):202. PubMed ID: 30258178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early detection of subclinical visual damage after blast-mediated TBI enables prevention of chronic visual deficit by treatment with P7C3-S243.
    Dutca LM; Stasheff SF; Hedberg-Buenz A; Rudd DS; Batra N; Blodi FR; Yorek MS; Yin T; Shankar M; Herlein JA; Naidoo J; Morlock L; Williams N; Kardon RH; Anderson MG; Pieper AA; Harper MM
    Invest Ophthalmol Vis Sci; 2014 Dec; 55(12):8330-41. PubMed ID: 25468886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The P7C3 class of neuroprotective compounds exerts antidepressant efficacy in mice by increasing hippocampal neurogenesis.
    Walker AK; Rivera PD; Wang Q; Chuang JC; Tran S; Osborne-Lawrence S; Estill SJ; Starwalt R; Huntington P; Morlock L; Naidoo J; Williams NS; Ready JM; Eisch AJ; Pieper AA; Zigman JM
    Mol Psychiatry; 2015 Apr; 20(4):500-8. PubMed ID: 24751964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective efficacy of aminopropyl carbazoles in a mouse model of Parkinson disease.
    De Jesús-Cortés H; Xu P; Drawbridge J; Estill SJ; Huntington P; Tran S; Britt J; Tesla R; Morlock L; Naidoo J; Melito LM; Wang G; Williams NS; Ready JM; McKnight SL; Pieper AA
    Proc Natl Acad Sci U S A; 2012 Oct; 109(42):17010-5. PubMed ID: 23027934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (-)-P7C3-S243 Protects a Rat Model of Alzheimer's Disease From Neuropsychiatric Deficits and Neurodegeneration Without Altering Amyloid Deposition or Reactive Glia.
    Voorhees JR; Remy MT; Cintrón-Pérez CJ; El Rassi E; Khan MZ; Dutca LM; Yin TC; McDaniel LN; Williams NS; Brat DJ; Pieper AA
    Biol Psychiatry; 2018 Oct; 84(7):488-498. PubMed ID: 29246437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GSK-3 inhibition through GLP-1R allosteric activation mediates the neurogenesis promoting effect of P7C3 after cerebral ischemic/reperfusional injury in mice.
    Wang YH; Liou KT; Tsai KC; Liu HK; Yang LM; Chern CM; Shen YC
    Toxicol Appl Pharmacol; 2018 Oct; 357():88-105. PubMed ID: 30189238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotective efficacy of aminopropyl carbazoles in a mouse model of amyotrophic lateral sclerosis.
    Tesla R; Wolf HP; Xu P; Drawbridge J; Estill SJ; Huntington P; McDaniel L; Knobbe W; Burket A; Tran S; Starwalt R; Morlock L; Naidoo J; Williams NS; Ready JM; McKnight SL; Pieper AA
    Proc Natl Acad Sci U S A; 2012 Oct; 109(42):17016-21. PubMed ID: 23027932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The neuroprotective compound P7C3-A20 promotes neurogenesis and improves cognitive function after ischemic stroke.
    Loris ZB; Pieper AA; Dietrich WD
    Exp Neurol; 2017 Apr; 290():63-73. PubMed ID: 28077334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P7C3 suppresses astrocytic senescence to protect dopaminergic neurons: Implication in the mouse model of Parkinson's disease.
    Chen Y; Zhu Z; Yan Y; Sun H; Wang G; Du X; Li F; Yuan S; Wang W; Wang M; Gu C
    CNS Neurosci Ther; 2024 Jul; 30(7):e14819. PubMed ID: 39056208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacologic rescue of motor and sensory function by the neuroprotective compound P7C3 following neonatal nerve injury.
    Kemp SWP; Szynkaruk M; Stanoulis KN; Wood MD; Liu EH; Willand MP; Morlock L; Naidoo J; Williams NS; Ready JM; Mangano TJ; Beggs S; Salter MW; Gordon T; Pieper AA; Borschel GH
    Neuroscience; 2015 Jan; 284():202-216. PubMed ID: 25313000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beneficial Effects of Delayed P7C3-A20 Treatment After Transient MCAO in Rats.
    Loris ZB; Hynton JR; Pieper AA; Dietrich WD
    Transl Stroke Res; 2018 Apr; 9(2):146-156. PubMed ID: 28842830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P7C3 inhibits GSK3β activation to protect dopaminergic neurons against neurotoxin-induced cell death in vitro and in vivo.
    Gu C; Zhang Y; Hu Q; Wu J; Ren H; Liu CF; Wang G
    Cell Death Dis; 2017 Jun; 8(6):e2858. PubMed ID: 28569794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.